Anesthesia Center for Critical Care Research, Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Circ Cardiovasc Imaging. 2012 Sep 1;5(5):652-9. doi: 10.1161/CIRCIMAGING.112.975607. Epub 2012 Jul 9.
Interventions to increase brown adipose tissue (BAT) volume and activation are being extensively investigated as therapies to decrease the body weight in obese subjects. Noninvasive methods to monitor these therapies in animal models and humans are rare. We investigated whether contrast ultrasound (CU) performed in mice could detect BAT and measure its activation by monitoring BAT blood flow. After validation, CU was used to study the role of uncoupling protein 1 and nitric oxide synthases in the acute regulation of BAT blood flow.
Blood flow of interscapular BAT was assessed in mice (n=64) with CU by measuring the signal intensity of continuously infused contrast microbubbles. Blood flow of BAT estimated by CU was 0.5±0.1 (mean±SEM) dB/s at baseline and increased 15-fold during BAT stimulation by norepinephrine (1 µg·kg(-1)·min(-1)). Assessment of BAT blood flow using CU was correlated to that performed with fluorescent microspheres (R(2)=0.86, P<0.001). To evaluate whether intact BAT activation is required to increase BAT blood flow, CU was performed in uncoupling protein 1-deficient mice with impaired BAT activation. Norepinephrine infusion induced a smaller increase in BAT blood flow in uncoupling protein 1-deficient mice than in wild-type mice. Finally, we investigated whether nitric oxide synthases played a role in acute norepinephrine-induced changes of BAT blood flow. Genetic and pharmacologic inhibition of nitric oxide synthase 3 attenuated the norepinephrine-induced increase in BAT blood flow.
These results indicate that CU can detect BAT in mice and estimate BAT blood flow in mice with functional differences in BAT.
增加棕色脂肪组织 (BAT) 体积和激活的干预措施正被广泛研究作为减少肥胖患者体重的治疗方法。用于监测动物模型和人体中这些治疗方法的非侵入性方法很少。我们研究了在小鼠中进行的对比超声 (CU) 是否可以通过监测 BAT 血流来检测 BAT 并测量其激活。经过验证后,CU 用于研究解偶联蛋白 1 和一氧化氮合酶在 BAT 血流的急性调节中的作用。
通过测量连续输注的对比微泡的信号强度,使用 CU 在小鼠(n=64)中评估肩胛间 BAT 的血流。CU 估计的 BAT 血流在基线时为 0.5±0.1(平均值±SEM)dB/s,在去甲肾上腺素(1μg·kg(-1)·min(-1))刺激 BAT 时增加 15 倍。使用 CU 评估 BAT 血流与使用荧光微球进行的评估相关(R(2)=0.86,P<0.001)。为了评估完整的 BAT 激活是否是增加 BAT 血流所必需的,在 BAT 激活受损的解偶联蛋白 1 缺陷型小鼠中进行了 CU。与野生型小鼠相比,去甲肾上腺素输注在解偶联蛋白 1 缺陷型小鼠中引起的 BAT 血流增加较小。最后,我们研究了一氧化氮合酶是否在急性去甲肾上腺素诱导的 BAT 血流变化中发挥作用。一氧化氮合酶 3 的遗传和药理学抑制减弱了去甲肾上腺素诱导的 BAT 血流增加。
这些结果表明,CU 可以在小鼠中检测到 BAT,并在 BAT 功能存在差异的小鼠中估计 BAT 血流。